The weekly litigation news digest is live. Subscribe now

Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production - EP3581650

The patent EP3581650 was granted to Uniqure Biopharma on Dec 28, 2022. The application was originally filed on Sep 15, 2009 under application number EP19174517A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3581650

UNIQURE BIOPHARMA
Application Number
EP19174517A
Filing Date
Sep 15, 2009
Status
Granted And Under Opposition
Nov 25, 2022
Publication Date
Dec 28, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

PFIZERSep 27, 2023PFIZERWITHDRAWN

Patent Citations (21) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2002166130
DESCRIPTIONUS2004102388
DESCRIPTIONUS2004110675
DESCRIPTIONUS2004133930
DESCRIPTIONUS2004254106
DESCRIPTIONUS2005100982
DESCRIPTIONUS2006040856
DESCRIPTIONUS2007093443
DESCRIPTIONUS2008003202
DESCRIPTIONUS6277618
DESCRIPTIONUS6315995
DESCRIPTIONUS6531298
DESCRIPTIONWO2006018201
DESCRIPTIONWO2006048777
DESCRIPTIONWO9903496
OPPOSITIONUS2008167219
OPPOSITIONWO9903496
OTHERUS9982248
OTHERWO9903496
SEARCHUS2008167219
SEARCHWO9903496

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents